MPS Pharmaa Limited (formerly Advik Laboratories Limited) successfully conducted its independent directors meeting for the Financial Year 2025-26 on March 25, 2026, in accordance with regulatory requirements. The meeting demonstrates the company's commitment to maintaining robust corporate governance standards and regulatory compliance.

Meeting Details and Regulatory Compliance

The independent directors meeting was held pursuant to Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015, read with Schedule IV of the Companies Act, 2013. The session took place at the company's corporate office located at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi-110001.

Key Agenda Items and Deliberations

The independent directors present at the meeting transacted specific business items as mandated by regulatory guidelines. The meeting focused on critical governance aspects that ensure effective board oversight and operational transparency.

The directors addressed two primary areas of evaluation:

• Performance Review: Comprehensive assessment of non-independent directors and overall board effectiveness
• Information Flow Assessment: Evaluation of quality, quantity, and timeliness of information exchange between company management and the board

Corporate Governance Framework

This independent directors meeting represents a crucial component of MPS Pharmaa Limited's corporate governance framework. The regulatory requirement ensures that independent directors can evaluate board performance and management effectiveness without the presence of executive directors, promoting transparency and accountability in corporate decision-making.

The company has notified both BSE Limited and Ahmedabad Stock Exchange Limited about the meeting outcome, maintaining compliance with listing obligations. Company Secretary Pooja Chuni signed the official communication to the stock exchanges, confirming the successful completion of the independent directors meeting and its compliance with all applicable regulations.

MPS Limited has announced the appointment of Ms. Deepti Singh as Chief People Officer and Senior Management Personnel, effective from the commencement of business hours on 23 March 2026. The company disclosed this appointment under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Appointment Details

The appointment details are structured as follows:

Professional Background and Experience

Ms. Deepti Singh brings over 16 years of global human resources leadership experience, having driven people strategies for high-growth technology organizations across India and North America. Her career demonstrates a proven track record of aligning people strategy with business priorities to build high-performance cultures and lead large-scale organizational transformations.

Most recently, Singh served as SVP, HR and Chief of Staff at Incedo Inc., where she operated at the intersection of strategic execution and talent scaling. In this role, she partnered with executive leadership to navigate multiple phases of global organizational evolution. Her previous experience includes pivotal roles at Flipkart during its primary era of scale, where she served as Chief of Staff to both the Chief People Officer and the Chief Operating Officer. She began her professional career at Target India.

Educational Qualifications and Expertise

Singh holds a Bachelor of Technology in Genetic Engineering and a PGDM in Human Resources and Industrial Relations. Her expertise spans multiple critical areas:

• Change management and consensus building
• Leadership development and talent succession planning
• Strategy to execution frameworks
• Employee engagement and internal communications
• Employer branding initiatives

Strategic Mandate at MPS Limited

In her capacity as Chief People Officer, Ms. Deepti Singh will be responsible for leading the global people strategy to strengthen organizational capability and instill a culture of surgical efficiency and high performance. Her strategic focus areas include:

The appointment reflects MPS Limited's commitment to strengthening its human capital strategy as the company expands into healthcare knowledge markets and other high-growth sectors. Singh's extensive experience in scaling organizations and driving transformational change positions her to support the company's strategic objectives through enhanced organizational capability and culture development.